Pernicious Anemia - Nursing Case Study
Pathophysiology
• Primary mechanism: Pernicious anemia is primarily caused by an autoimmune destruction of gastric parietal cells, leading to a deficiency of intrinsic factor, a protein essential for vitamin B12 absorption in the ileum.
• Secondary mechanism: The lack of intrinsic factor results in impaired vitamin B12 absorption, causing a decrease in DNA synthesis in red blood cell precursors, leading to the production of large, immature, and dysfunctional megaloblastic red blood cells.
• Key complication: The resultant vitamin B12 deficiency can lead to neurological complications due to its role in myelin synthesis, potentially causing peripheral neuropathy and cognitive disturbances if untreated.
Patient Profile
Demographics:
56-year-old female, office manager
History:
• Key past medical history: Diagnosed with pernicious anemia 3 years ago, history of hypothyroidism
• Current medications: Vitamin B12 injections, Levothyroxine 75 mcg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing fatigue and numbness in extremities
• Key symptoms: Persistent fatigue, numbness and tingling in hands and feet, shortness of breath on exertion, occasional dizziness
• Vital signs: Blood pressure 140/90 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 37.2°C
Section 1
Following the initial presentation, the healthcare team conducted a thorough assessment to better understand the extent of the patient's condition and any emerging complications. Physical examination revealed pallor of the skin and mucous membranes, consistent with her history of pernicious anemia. Neurological assessment showed decreased vibratory sensation and proprioception in the lower extremities, suggesting the advancement of peripheral neuropathy. The patient's gait was slightly unsteady, further indicating potential neurological involvement. Auscultation of the heart revealed a mild systolic murmur, which had not been noted in previous evaluations, raising concern for possible high-output cardiac failure secondary to chronic anemia.
Laboratory tests were ordered to evaluate the current status of her anemia and to explore other potential causes of her symptoms. Complete blood count (CBC) results showed a hemoglobin level of 8.5 g/dL and mean corpuscular volume (MCV) of 110 fL, confirming macrocytic anemia. Serum vitamin B12 levels were markedly low at 150 pg/mL, despite ongoing intramuscular injections, indicating possible malabsorption issues or non-compliance. Folate levels were within normal limits, ruling out folate deficiency as a contributing factor to her macrocytic anemia. Thyroid function tests revealed a slightly elevated TSH level of 5.0 mIU/L, potentially indicating suboptimal dosing of her Levothyroxine, which could contribute to her symptoms of fatigue.
Upon reviewing these findings, the healthcare team considered the possibility of additional complications such as subacute combined degeneration of the spinal cord due to prolonged vitamin B12 deficiency. This necessitated a multidisciplinary approach, involving neurology for further evaluation of her neurological symptoms, as well as potential adjustments in her vitamin B12 therapy. The team also planned for an echocardiogram to assess the newly discovered heart murmur and rule out underlying cardiac issues. This nuanced understanding of her condition highlighted the need for ongoing monitoring and tailored interventions to address the multifaceted challenges posed by pernicious anemia.
Section 2
Following the initial assessment and the identification of potential complications, the healthcare team decided to prioritize the investigation into the patient's new neurological symptoms. A neurology consultation was conducted, and further diagnostic imaging, including an MRI of the spine, was ordered. The MRI results revealed hyperintensity in the posterior columns of the spinal cord, consistent with subacute combined degeneration, a condition often resulting from prolonged vitamin B12 deficiency. This finding corroborated the clinical signs of decreased proprioception and vibratory sensation, as well as the patient's unsteady gait. These results suggested that the patient's neurological symptoms were not only a consequence of peripheral neuropathy but also indicative of central nervous system involvement due to her chronic condition.
In response to these findings, the healthcare team adjusted the patient's vitamin B12 therapy regimen. They switched from monthly intramuscular injections to weekly injections, accompanied by high-dose oral supplementation, to address potential absorption issues and ensure adequate levels of the vitamin. The team also reviewed her Levothyroxine dosing, considering a slight increase to manage her borderline hypothyroidism, which was contributing to her fatigue. The patient was referred to physical therapy to aid in improving her gait and balance, aiming to prevent falls and improve her quality of life.
As the patient continued with her revised treatment plan, close monitoring was essential. Follow-up laboratory tests were scheduled to evaluate the effectiveness of the new vitamin B12 regimen, along with repeat thyroid function tests to assess the impact of the adjusted Levothyroxine dose. The multidisciplinary approach aimed to address the complex interplay of her symptoms, with the hope of mitigating further neurological damage and managing her anemia more effectively. This comprehensive strategy highlighted the importance of vigilant monitoring and timely intervention in managing chronic conditions like pernicious anemia, which can have widespread systemic effects if not carefully managed.
Section 3
As the weeks progressed, the patient's response to the intensified vitamin B12 therapy and modified Levothyroxine dosing showed promising initial results. During a follow-up evaluation, the healthcare team observed that her energy levels had gradually improved, and she reported feeling less fatigued. Her gait, while still unsteady, demonstrated slight improvements, attributed to both the physical therapy sessions and the correction of her vitamin deficiencies. Vital signs were stable, with a blood pressure of 118/76 mmHg, a heart rate of 72 beats per minute, and a respiratory rate of 16 breaths per minute. However, the patient expressed concern about persistent numbness and tingling in her hands and feet, indicating ongoing peripheral neuropathy.
Laboratory tests conducted to assess the effectiveness of the treatment plan revealed a notable improvement in her serum vitamin B12 levels, which had increased from a critically low level of 120 pg/mL to a more adequate level of 450 pg/mL. Her hemoglobin levels also showed improvement, rising to 11.5 g/dL from a previous 9.8 g/dL, reflecting a positive response in addressing her anemia. Thyroid function tests indicated a slight improvement in her TSH levels, adjusting to 2.5 mIU/L, suggesting that the adjusted Levothyroxine dosage was contributing positively to her overall condition.
Despite these improvements, the persistent neurological symptoms warranted further investigation. The healthcare team decided to conduct additional nerve conduction studies to better understand the extent and nature of her neuropathy. This next step was crucial in tailoring her ongoing treatment plan, considering the potential need for additional therapies to manage her neuropathic symptoms effectively. The unfolding case highlighted the importance of continuous evaluation and adaptability in treatment strategies to address both the immediate and long-term needs of patients with complex conditions like pernicious anemia.
Section 4
Two weeks later, during a routine follow-up visit, the patient presented with new symptoms, including increased difficulty with balance and more pronounced numbness in her extremities. Her gait had become more unsteady despite ongoing physical therapy, raising concerns about the progression of her neuropathy. The healthcare team also noted that the patient had developed a mild tremor in her hands, which was not previously observed. Her vital signs remained stable, with a blood pressure of 120/78 mmHg, a heart rate of 74 beats per minute, and a respiratory rate of 18 breaths per minute. Given these new developments, there was a strong suspicion of an evolving neurological complication.
The results of the nerve conduction studies revealed a moderate peripheral neuropathy, characterized by both sensory and motor deficits. These findings were consistent with a length-dependent neuropathy, commonly seen in vitamin B12 deficiency. Despite the improvement in serum vitamin B12 levels, the persistent and worsening symptoms suggested that the nerve damage might be irreversible or slowly recovering. Additionally, the patient's folate levels were checked and found to be at the lower end of normal, which could potentially exacerbate neurological symptoms if not addressed promptly.
Considering these results, the healthcare team decided to adjust the patient's treatment plan. They recommended initiating folate supplementation to support nerve health and prevent further deterioration of her neurological status. Recognizing the need for a multidisciplinary approach, a referral to a neurologist was also made to explore additional therapeutic options, such as medications specifically targeting neuropathic pain and further tailored physical therapy strategies. This comprehensive approach aimed to address the complex interplay of factors contributing to her condition, highlighting the importance of proactive management and vigilant monitoring in the care of patients with pernicious anemia and its complications.
Section 5
Two weeks after initiating folate supplementation and receiving care from the multidisciplinary team, the patient returned for another follow-up appointment. During the assessment, the healthcare team observed mixed progress. The patient reported a slight reduction in the intensity of her hand tremor and a minor improvement in balance, indicating some positive response to the interventions. However, she continued to experience significant numbness in her extremities, particularly in her feet, which persisted despite the current treatment regimen. Her gait remained unsteady, and she expressed frustration over her limited mobility, which was affecting her daily activities and quality of life.
The team conducted a thorough neurological examination, which revealed persistent deficits. The patient's deep tendon reflexes were diminished in the lower extremities, and proprioception was notably impaired. Laboratory evaluations showed that her serum folate levels had improved to within the normal range, suggesting adequate supplementation. However, her hemoglobin remained at the lower end of normal, and a repeat complete blood count indicated a slight macrocytosis, pointing toward ongoing issues related to her anemia.
In light of these findings, the healthcare team decided to intensify the management plan. They increased the frequency of her physical therapy sessions to enhance neuromuscular coordination and prescribed a low-dose gabapentin to help manage neuropathic pain and discomfort. Additionally, the neurologist recommended an MRI of the brain and spinal cord to rule out other potential causes of her symptoms, such as structural abnormalities or additional neurological disorders. This proactive approach aimed to address lingering complications while maintaining vigilance for any new developments in her condition.